Home » Funding & investments » News Digest #224 – Join us live at Amyris today, Early bird ends Friday + 5 companies raise $278M

News Digest #224 – Join us live at Amyris today, Early bird ends Friday + 5 companies raise $278M


Hi all,

Join me live this morning for a SynBioBeta Deep Dive at 8:00 am Pacific with Labcyte and Amyris. Learn how acoustic dispensing will become an instrumental technology in the synthetic biology industry by increasing strain construction efficiency and reducing reaction volumes.

What would you create with 100,000 free base pairs of DNA? That’s the question that IDT is asking synthetic biologists who are seeking to change the world for the better. Learn more about the contest and apply here.

I’m pleased to announce a special SynbiCITE webinar on global trends and business opportunities in synthetic biology that will take place next Thursday, July 5. Synthetic Biology Week will take place Sept 30 – Oct 6 during SynBioBeta, with activities ranging from lab tours to hikes to workshops and talks, hands-on activities and events for everyone to enjoy. Watch for the full announcement next week.

It’s time for pharma to take another look at synthetic biology, says Codexis CEO John Nicols in conversation with Kevin Costa of SynBioBeta. “The world’s pharmaceutical industry needs to take a lesson from [the likes of] Merck and GSK and get more proactive in exploiting the growing power of synthetic biology to improve its business going forward.” You can meet John Nicols at SynBioBeta 2018.

This week we explore how, from cell culture to table culture, the social and industrial landscape is shifting where food and biotechnology meet. Food tech need not replace beloved, traditional foods like brie and burgers overnight, but rather it can simply offer new alternatives to reflect consumers’ evolving tastes for natural and sustainable eats.

Who raised funding this week? London-based Autolus raised an impressive $150 million on NASDAQ IPO to boost the development of T cell therapies for cancer; Precision BioSciences closed a $110M Series B to advance their genome editing platform, Catalog raised $9 million to make DNA-based data storage commercially viable, Finless Foods closed a $3.5 million seed round to develop environmentally-friendly seafood products, and Checkerspot closed $5 million in a seed financing to design new biomaterials at a molecular level. Charles Dimmler, CEO of the company, will be speaking at SynBioBeta, along with these new speakers:

Register for SynBioBeta by Friday and receive your early bird discount.

Finally, what can synthetic biologists learn from astronaut Scott Kelly? Our writer Natalie Slivinski had the pleasure of seeing him speak in Seattle. His underlying message: the importance of reaching, sometimes literally, for the stars.


Helping plants remove natural toxins could boost crop yields by 47 percent
Green Biologics announces launch of first bio-based acetone nail polish remover
Pheronym wins grant for eco-friendly pest control for interstellar agriculture
Gevo and Avfuel enter into renewable jet fuel supply agreement
Department of Energy announces $40 Million for bio-based research
Genetically modified bacteria enlisted in fight against disease

All the News

Synpromics announces that CEO David Venables won the ‘Disruptor’ category of Scotland’s EY Entrepreneur Of The Year 2018

Modern Meadow awarded as Technology Pioneer by World Economic Forum for its contributions in the field of biofabrication (Press release)

ProteinQure taps quantum power in search of protein-based therapies

A new report looks at opportunities for synthetic biology in advanced materials (Knowledge Transfer Network)

New Wilmar-NUS joint lab to drive innovation in food-tech and sustainable biochemicals

Synlogic presents new preclinical data from Synthetic Biotic™ Immuno-Oncology program at FOCIS 2018 (Press release)

KnipBio awarded SBIR Phase I grant to investigate effect of dietary components on fish health (Press release)

Twist Bioscience expands executive team with industry veterans (Press release)

Synthetic Genomics appoints Reinhard J. Ambros, Ph.D., Former Global Head of the Novartis Venture Fund to board of directors (Press release)

Battling constipation with synthetic biology and DNA manipulation (Genetic Literacy Project)

Who’s Hiring?

Biotechnology Policy Analyst, J. Craig Venter Institute, San Diego, CA

Event Producer and Marketing Manager – SynBioBeta

Executive Assistant – SynBioBeta

Sales Support Specialist – SynBioBeta

Associate Creative Producer: Video, Visual & Editorial Content – SynBioBeta

Fermentation Scientist: DNA Script, Paris, France

Synthetic biologist/Protein engineer: XENO Cell Innovations, Pilsen, Czech Republic

To feature your job here, please get in touch

Copyright © %%current_year_YYYY%%, All rights reserved.

1547 Palos Verdes Mall, #411
Walnut Creek, CA 94597

About Us | Update Preferences | Unsubscribe | View email in your browser

Click here to join our weekly newsletter. We want to hear what you think about this article. Got a tip for our news team? Write to editorial@synbiobeta.com.

Editor’s picks